Lung Cancer Research Foundation

Open programs2

1. 2026 LCRF | AstraZeneca Research Award — Strategies Towards Improving the Treatment of Small Cell Lung Cancer

   Lung Cancer Research Foundation (LCRF), in collaboration with AstraZeneca, is launching two SCLC-focused awards: a $500,000, three-year grant to advance novel strategies for improving small cell lung cancer treatment (including correlative translational research) and a $250,000, two-year grant to develop patient advocacy strategies that improve outcomes across the care continuum.

   Research ProjectHealth

   Deadline

   Not listed

   Amount

   $500,000

2. LCRF | Boehringer Ingelheim Team Science Award for HER2-mutant Lung Cancer Research

   The Lung Cancer Research Foundation, in collaboration with Boehringer Ingelheim, offers the LCRF | Boehringer Ingelheim Team Science Award to support multidisciplinary, high‑reward research focused on understanding and developing therapeutic strategies for HER2‑mutant non–small cell lung cancer, including projects addressing tyrosine kinase inhibitor resistance and drug‑tolerant persister cells; a recent recipient team received a $1.5M grant.

   Research ProjectHealth

   Deadline

   Not listed

   Amount

   $1,500,000

Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.